For study partners and sponsors

Research and care for your health

The CED-Studienzentrum Karlshorst is a specialized trial center for clinical studies on chronic inflammatory bowel diseases (IBD). We have many years of experience, established structures and a reliable study infrastructure.

Our center collaborates with pharmaceutical companies, CROs, university institutions and other research partners.
In collaboration with qualified research partners and subject to review by independent ethics committees.

Profile of the study center

The study center specializes in clinical trials for Crohn’s disease, ulcerative colitis and other chronic inflammatory bowel diseases. It is managed by experienced gastroenterologists, supported by qualified study nurses and a structured study coordination team. We have experience in conducting Phase II to Phase IV studies. Established SOP processes as well as audit and inspection readiness are guaranteed.

Quality and compliance standards

  • Implementation according to ICH-GCP
  • Review by independent ethics committees
  • Documentation in sponsor EDC systems as specified
  • Standardized reporting of AEs/SAEs
  • Regular internal quality controls
  • Protocol deviation management according to SOP

All employees have valid GCP certificates and receive regular training.

Infrastructure and examination conditions

  • Connection to a modernly equipped gastroenterological practice
  • Separate study rooms for anamnesis, examinations and documentation
  • Endoscopy with high-resolution technology (can be named more precisely if desired)
  • Laboratory analysis (internal / external – please add if relevant)
  • Storage areas with temperature monitoring for investigational medicinal products
  • Secure archiving and documentation in accordance with GCP requirements
  • Barrier-free access and good transport connections

Recruitment and patient population

Recruitment includes patients with moderate to severe chronic inflammatory bowel diseases. Both early and advanced stages of the disease are taken into account. Screening and preliminary assessment are carried out in a structured manner by the medical study team.

Recruitment takes place via the practice’s internal patient base, via regional referrers and via digital inquiries to the study center. High retention is supported by permanent contact persons, clear appointment structures and short distances within the center.

Investigator team & study coordination

Dr. med. Susanna Scharrer

Specialist in internal medicine and gastroenterology

Focus: Chronic inflammatory bowel diseases, interventional endoscopy and sonography

Dr. med. Thomas Brunk

Specialist in internal medicine and gastroenterology
Hematology and internal oncology

Focus: Gastrointestinal oncology

Richard Juma Otwo

Study Nurse

• Performing study-relevant examinations
• Documentation in the eCRF
• Coordination of all visit appointments

Nadine Petco

Study coordinator

• Appointment coordination
• Communication with CRAs/sponsors
• Administration of documents and investigator files (ISF/SMF)
• Logistics and documentation processes

Viola Heller

Study assistant

Electronic systems and documentation

  • Support for all common EDC systems
  • Use of eCRFs according to sponsor specifications
  • Digital and physical archiving
  • Temperature documentation of the investigational medicinal product
  • Responsible for data management and queries

Current studies

Collaboration and communication with sponsors/CROs

Collaboration with sponsors and CROs is characterized by short response times, transparent communication and structured coordination in all study phases.

This includes the start-up, maintenance and close-out phase. Monitor visits are scheduled flexibly and reliably. The study center supports feasibility assessments and participates in investigator meetings if required.